LCAR-BCDR Cells / Legend Biotech - LARVOL DELTA

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - P1 | N=24 | Terminated | Sponsor: Weijun Fu | Trial completion date: Sep 2026 ➔ May 2025 | Recruiting ➔ Terminated | Trial primary completion date: Jun 2024 ➔ May 2025; Per sponsor request

Trial completion date • Trial primary completion date • Trial termination • Hematological Malignancies • Multiple Myeloma • Oncology

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Weijun Fu | Not yet recruiting ➔ Recruiting

Enrollment open • Hematological Malignancies • Multiple Myeloma • Oncology